These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 175640)

  • 1. Human ecto- and endocervical epithelial cells as targets for herpes simplex type two infection in vitro.
    Vesterinen E
    Acta Pathol Microbiol Scand B; 1976 Feb; 84(1):29-37. PubMed ID: 175640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of latent Herpes simplex virus type 2 infection in human cervical epithelial cells in vitro.
    Vesterinen E; Leinikki P; Saksela E
    Acta Pathol Microbiol Scand B; 1977 Oct; 85B(5):289-95. PubMed ID: 203162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytopathogenicity of cytomegalovirus to human ecto- and endocervical epithelial cells in vitro.
    Vesterinen E; Leinikki P; Saksela E
    Acta Cytol; 1975; 19(5):473-81. PubMed ID: 170769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus infection and cytopathic alterations of human cervical epithelial cells in vitro.
    Vesterinen E; Vaheri A; Paavonen J; Saksela E
    Acta Cytol; 1978; 22(6):566-9. PubMed ID: 282757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoblotting and enzyme-linked immunosorbent assay analysis of serological responses in patients infected with herpes simplex virus types 1 and 2.
    Lehtinen M; Koivisto V; Lehtinen T; Paavonen J; Leinikki P
    Intervirology; 1985; 24(1):18-25. PubMed ID: 2995271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of oral tissues to herpes simplex virus--in vitro.
    Rones Y; Hochman N; Ehrlich J; Zakay-Rones Z
    J Periodontol; 1983 Feb; 54(2):91-5. PubMed ID: 6300365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiidiotype modulation of herpes simplex virus infection leading to increased pathogenicity.
    Kennedy RC; Adler-Storthz K; Burns JW; Henkel RD; Dreesman GR
    J Virol; 1984 Jun; 50(3):951-3. PubMed ID: 6202879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of in vivo depletion of immunocyte populations on herpes simplex virus glycoprotein D vaccine-induced resistance to HSV2 challenge.
    Mishkin EM; Blasiak M; Giorgio D; Ishizaka ST
    Viral Immunol; 1992; 5(2):151-61. PubMed ID: 1319710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with herpes-simplex viruses 1 and 2. II.
    Nahmias AJ; Roizman B
    N Engl J Med; 1973 Oct; 289(14):719-25. PubMed ID: 4353782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta-9-tetrahydrocannabinol inhibits the splenocyte proliferative response to herpes simplex virus type 2.
    Cabral GA; McNerney PJ; Mishkin EM
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):361-70. PubMed ID: 2830329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vertical transmission of type I and type 2 Herpes simplex virus infection in hamsters.
    Kurata K; Kurata T; Aoyama Y
    Jpn J Exp Med; 1976 Jun; 46(3):187-95. PubMed ID: 183033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Fc receptors in herpes simplex virus infection.
    Costa JC; Rabson AS
    Lancet; 1975 Jan; 1(7898):77-8. PubMed ID: 46027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus-specific antigens in exfoliated cervical cells from women with and without cervical anaplasia.
    Pacsa AS; Kummerländer L; Pejtsik B; Krommer K; Pali K
    Cancer Res; 1976 Jul; 36(7 PT 1):2130-2. PubMed ID: 179696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
    Zaia JA; Palmer EL; Feorino PM
    J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between antigenic type of virus and antibody response in female patients with herpes genitalis.
    Ozaki Y; Ishiguro T; Ohashi M; Kimura EM
    J Med Virol; 1980; 5(3):249-56. PubMed ID: 6262452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus-induced epithelial damage and susceptibility to human immunodeficiency virus type 1 infection in human cervical organ culture.
    Horbul JE; Schmechel SC; Miller BR; Rice SA; Southern PJ
    PLoS One; 2011; 6(7):e22638. PubMed ID: 21818356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Herpes-simplex-virus antigens in normal cervical cells.
    Pacsa AS; Kummerländer L; Pejtsik B; Simon M; Pali K
    Lancet; 1976 Mar; 1(7959):597. PubMed ID: 55882
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
    Cunningham AL; Noble JR
    J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of virus-specific antigens in extracts from herpes simplex virus-infected cells by a Cr release inhibition test.
    Kutinová L; Vonka V
    Infect Immun; 1978 Jun; 20(3):587-91. PubMed ID: 78899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies.
    Moller-Larsen A; Heron I; Haahr S
    Infect Immun; 1977 Apr; 16(1):43-7. PubMed ID: 194838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.